← All diseases
Cancer
Esophageal cancer
Do you want to be notified when there is new research about Esophageal Cancer? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, one sentence above each publication explains what was studied — and you'll be notified as soon as new research on Esophageal Cancer is available. View what Premium costs.
Publications and studies (2589)
- Targeting mutant p53-R248w reactivates WT p53 function and alters the onco-metabolic profile. (2023/01/11) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Epigenetic modifications in esophageal cancer: An evolving biomarker. (2023/01/10) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Immune evasion in esophageal squamous cell cancer: From the perspective of tumor microenvironment. (2023/01/09) ♡
- Relationship between postoperative nodal skip metastasis of mid-thoracic esophageal squamous cell carcinoma and patient prognosis and its value in guiding postoperative adjuvant treatment. (2023/01/09) ♡
- Indocyanin green near-infrared imaging-guided lymph node dissection during oesophageal cancer surgery: A single-centre experience. (2023/01/09) ♡
- Study of the short-term quality of life of patients with esophageal cancer after inflatable videoassisted mediastinoscopic transhiatal esophagectomy. (2023/01/06) ♡
- Risk factors for early local lymph node recurrence of thoracic ESCC after McKeown esophagectomy. (2023/01/06) ♡
- Two-rope method for esophageal dissection in McKeown MIE. (2023/01/06) ♡
- Risk factors for distant metastasis and prognosis in stage T1 esophageal cancer: A population-based study. (2023/01/06) ♡
- Construction and validation of a nomogram model to predict the overall survival rate of esophageal cancer patients receiving neoadjuvant chemotherapy: A population-based study. (2023/01/06) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case report: Visibly curative effect of dabrafenib and trametinib on advanced thyroid carcinoma in 2 patients. (2023/01/05) ♡
- Predictive value of systemic immune-inflammation index for pathological complete response in patients receiving neoadjuvant immunochemotherapy for locally advanced esophageal cancer. (2023/01/04) ♡
- Predictive nomogram for postoperative atrial fibrillation in locally advanced esophageal squamous carcinoma cell with neoadjuvant treatment. (2023/01/04) ♡
- Comprehensive pan-cancer analysis and the regulatory mechanism of AURKA, a gene associated with prognosis of ferroptosis of adrenal cortical carcinoma in the tumor microenvironment. (2023/01/04) ♡
- A novel pyroptosis scoring model was associated with the prognosis and immune microenvironment of esophageal squamous cell carcinoma. (2023/01/04) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Prognostic value of lymph node micrometastasis in esophageal cancer: A systematic review and meta-analysis. (2023/01/04) ♡
- A nomogram model to individually predict prognosis for esophageal cancer with synchronous pulmonary metastasis. (2023/01/04) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Iron intake and multiple health outcomes: Umbrella review. (2023/01/01) ♡
- Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients. (2023/01/01) ♡
- Anticipated cancer burden of low individual fruit and vegetable consumption under climate change: A modelling study in China. (2023/01/01) ♡
- Peripheral Blood Markers Predictive of Progression-Free Survival in Advanced Esophageal Squamous Cell Carcinoma Patients Treated With PD-1 Inhibitors Plus Chemotherapy as First-Line Therapy. (2023/01/01) ♡
- Controlling Nutritional Status Score Serves as a Prognosticator in Esophageal Squamous Cell Carcinoma: Optimal Timing of Evaluation of Patients Undergoing Neoadjuvant Treatment. (2023/01/01) ♡
- Safety and efficacy of double-tract reconstruction with remnant stomach conservation in esophagectomy for patients with a history of distal gastrectomy. (2023/01/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. The Prognostic Role of GLIM Criteria in Postoperative Outcomes after Upper Gastrointestinal Cancer Surgery: A Meta-Analysis of Observational Studies. (2023/01/01) ♡
- PPDPF Promotes the Development of Mutant KRAS-Driven Pancreatic Ductal Adenocarcinoma by Regulating the GEF Activity of SOS1. (2023/01/01) ♡
- Canned Fish Consumption and Upper Digestive Tract Cancers. (2023/01/01) ♡
- Retracted publicationiThis research has been withdrawn by science itself, for example due to a flaw in the method or unreliable data. Do not use it as support and do not discuss it as evidence. Icariin as an emerging candidate drug for anti-cancer treatment: Current status and perspective. (2023/01/01) ♡
- Network Pharmacological Study of Compound Kushen Injection in Esophageal Cancer. (2023/01/01) ♡
- Proton Pump Inhibitors Modulate Gene Expression Profile in Esophageal Mucosa and Microbiome. (2023/01/01) ♡
- Identification of a cRNA Network Driven by Copy Number Variations in Esophageal Cancer. (2023/01/01) ♡
- Robotic-assisted minimally invasive esophagectomy - our first experience. (2023/01/01) ♡
- Comments on National guidelines for diagnosis and treatment of esophageal carcinoma 2022 in China (English version). (2022/12/30) ♡
- Postoperative functional evaluation of gastrectomy for gastric cancer. (2022/12/30) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The "Light Knife" for Gastric Cancer: Photodynamic Therapy. (2022/12/28) ♡
- Thoracic para-aortic lymph node recurrence in patients with esophageal squamous cell carcinoma: A propensity score-matching analysis. (2022/12/26) ♡
- Oral higher dose prednisolone to prevent stenosis after endoscopic submucosal dissection for early esophageal cancer. (2022/12/26) ♡
- The Role of Age and Comorbidities in Esophagogastric Cancer Chemoradiation of the Frail Elderly (>70 Years): An Analysis from a Tertiary High Volume Center. (2022/12/23) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Diet and Esophageal Cancer Risk: An Umbrella Review of Systematic Reviews and Meta-Analyses of Observational Studies. (2022/12/22) ♡
- Trifluridine/Tipiracil in the Real-World Management of Metastatic Gastric and Gastroesophageal Junction Cancers in Canada. (2022/12/22) ♡
- A combined predicting model for benign esophageal stenosis after simultaneous integrated boost in esophageal squamous cell carcinoma patients (GASTO1072). (2022/12/22) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Primary esophageal malignant melanoma without recurrence after surgery and adjuvant therapy with nivolumab. (2022/12/21) ♡
- Identification of Differentially Expressed Genes Related to the Lipid Metabolism of Esophageal Squamous Cell Carcinoma by Integrated Bioinformatics Analysis. (2022/12/20) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Best Supportive Care of the Patient with Oesophageal Cancer. (2022/12/19) ♡
- Proton Therapy With Concurrent Chemotherapy for Thoracic Esophageal Cancer: Toxicity, Disease Control, and Survival Outcomes. (2022/12/19) ♡
- Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Chemoradiotherapy with concurrent durvalumab for the palliative treatment of oligometastatic oesophageal and gastrooesophageal carcinoma with dysphagia: a single arm phase II clinical trial (PALEO, sponsored by the Australasian Gastro-Intestinal Trials Group). (2022/12/17) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Recent advances in esophageal squamous cell precancerous conditions: A review. (2022/12/16) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Two Cases of Subsequent Hepatocellular Carcinoma in Immune Checkpoint Inhibitor-Responsive NSCLC: A Case Report. (2022/12/16) ♡
- A role for age-associated alterations in esophageal epithelium in eosinophilic esophagitis-associated fibrosis. (2022/12/15) ♡
- Global burden of cancers attributable to tobacco smoking, 1990-2019: an ecological study. (2022/12/15) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Multi-Site, International Audit of Malnutrition Risk and Energy and Protein Intakes in Patients Undergoing Treatment for Head Neck and Esophageal Cancer: Results from INFORM. (2022/12/10) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.